Coenzima Q10 (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Coenzima Q10" in Spanish language version.

refsWebsite

Global rank Spanish rank

32nih.gov

4^th place

31doi.org

2^nd place

6issn.org

57^th place

3^rd place

3elsevier.com

610^th place

332^nd place

1nist.gov

355^th place

83^rd place

1archive.org

6^th place

5^th place

1wkhealth.com

low place

4,276^th place

1cancer.gov

1,684^th place

1,021^st place

1wiley.com

222^nd place

135^th place

1neurology.org

9,919^th place

7,146^th place

1web.archive.org

1^st place

1cancer.org

3,680^th place

3,012^th place

1lww.com

2,769^th place

2,119^th place

1oup.com

485^th place

502^nd place

1worldcat.org

5^th place

10^th place

archive.org

Dutton, PL; Ohnishi, T; Darrouzet, E; Leonard, MA; Sharp, RE; Cibney, BR; Daldal, F; Moser, CC (2000). «4 Coenzyme Q oxidation reduction reactions in mitochondrial electron transport». En Kagan, VE; Quinn, PJ, eds. Coenzyme Q: Molecular mechanisms in health and disease. Boca Raton: CRC Press. pp. 65–82.

cancer.gov

White, J. (lead reviewer); National Cancer Institute (NCI) (14 de mayo de 2014). «PDQ® Coenzyme Q10». NCI, National Institutes of Health, US Dept. of Health and Human Services. Consultado el 29 de junio de 2014.

cancer.org

«Coenzyme Q10». American Cancer Society. Archivado desde el original el 24 de febrero de 2014. Consultado el 20 de febrero de 2014.

doi.org

dx.doi.org

Ernster, L; Dallner, G (1995). «Biochemical, physiological and medical aspects of ubiquinone function». Biochimica et Biophysica Acta 1271 (1): 195-204. PMID 7599208. doi:10.1016/0925-4439(95)00028-3.
Aberg, F; Appelkvist, EL; Dallner, G; Ernster, L (1992). «Distribution and redox state of ubiquinones in rat and human tissues». Archives of biochemistry and biophysics 295 (2): 230-4. PMID 1586151. doi:10.1016/0003-9861(92)90511-T.
Shindo, Y; Witt, E; Han, D; Epstein, W; Packer, L (1994). «Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin». The Journal of investigative dermatology 102 (1): 122-4. PMID 8288904. doi:10.1111/1523-1747.ep12371744.
Trevisson E, Dimauro S, Navas P, Salviati L (October 2011). «Coenzyme Q deficiency in muscle». Curr. Opin. Neurol. 24 (5): 449-56. PMID 21844807. doi:10.1097/WCO.0b013e32834ab528.
Hyson HC, Kieburtz K, Shoulson I, et al. (September 2010). «Safety and tolerability of high-dosage coenzyme Q₁₀ in Huntington's disease and healthy subjects». Mov. Disord. 25 (12): 1924-8. PMID 20669312. doi:10.1002/mds.22408.
Hathcock JN, Shao A (August 2006). «Risk assessment for coenzyme Q₁₀ (Ubiquinone)». Regul. Toxicol. Pharmacol. 45 (3): 282-8. PMID 16814438. doi:10.1016/j.yrtph.2006.05.006.
Montero R, Sánchez-Alcázar JA, Briones P, et al. (June 2008). «Analysis of coenzyme Q₁₀ in muscle and fibroblasts for the diagnosis of CoQ₁₀ deficiency syndromes». Clin. Biochem. 41 (9): 697-700. PMID 18387363. doi:10.1016/j.clinbiochem.2008.03.007.
Mortensen, SA; Leth, A; Agner, E; Rohde, M (1997). «Dose-related decrease of serum coenzyme Q₁₀ during treatment with HMG-CoA reductase inhibitors». Molecular aspects of medicine 18 (Suppl): S137-44. PMID 9266515. doi:10.1016/S0098-2997(97)00014-9.
Ghirlanda, G; Oradei, A; Manto, A; Lippa, S; Uccioli, L; Caputo, S; Greco, AV; Littarru, GP (1993). «Evidence of plasma CoQ₁₀-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study». Journal of Clinical Pharmacology 33 (3): 226-9. PMID 8463436. doi:10.1002/j.1552-4604.1993.tb03948.x.
Sarter, B (2002). «Coenzyme Q₁₀ and cardiovascular disease: a review». Journal of Cardiovascular Nursing 16 (4): 9-20. PMID 12597259. doi:10.1097/00005082-200207000-00003.
Wyman M, Leonard M, Morledge T (July 2010). «Coenzyme Q10: a therapy for hypertension and statin-induced myalgia?». Cleve Clin J Med 77 (7): 435-42. PMID 20601617. doi:10.3949/ccjm.77a.09078.
Madmani, M.E.; Yusuf Solaiman, A.; Tamr Agha, K.; Madmani, Y. et al. (2 de junio de 2014). «Coenzyme Q10 for heart failure». Heart Group. Cochrane Database of Systematic Reviews (John Wiley & Sons) (6): Art. no. CD008684. doi:10.1002/14651858.CD008684.pub2 – via The Cochrane Library. (requiere suscripción).
Ho, MJ; Bellusci, A; Wright, JM (7 de octubre de 2009). «Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.». The Cochrane database of systematic reviews (4): CD007435. PMID 19821418. doi:10.1002/14651858.CD007435.pub2.
Fotino, A Domnica; Thompson-Paul, Angela M; Bazzano, Lydia A (2013-2). «Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis123». The American Journal of Clinical Nutrition 97 (2): 268-275. ISSN 0002-9165. PMC 3742297. PMID 23221577. doi:10.3945/ajcn.112.040741. Consultado el 7 de mayo de 2018.
Lei, Li; Liu, Yan (07 24, 2017). «Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials». BMC cardiovascular disorders 17 (1): 196. ISSN 1471-2261. PMC 5525208. PMID 28738783. doi:10.1186/s12872-017-0628-9. Consultado el 7 de mayo de 2018.
DiNicolantonio, James J; Bhutani, Jaikrit; McCarty, Mark F; O'Keefe, James H (19 de octubre de 2015). «Coenzyme Q10 for the treatment of heart failure: a review of the literature». Open Heart 2 (1). ISSN 2053-3624. PMC 4620231. PMID 26512330. doi:10.1136/openhrt-2015-000326. Consultado el 7 de mayo de 2018.
Armstrong, M. J.; Miyasaki, J. M. (7 de agosto de 2012). «Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology». Neurology (en inglés) 79 (6): 597-603. ISSN 0028-3878. PMC 3413759. PMID 22815556. doi:10.1212/WNL.0b013e318263c443. Consultado el 30 de octubre de 2020.
Lafuente, R; González-Comadrán, M; Solà, I; López, G; Brassesco, M; Carreras, R; Checa, MA (Sep 2013). «Coenzyme Q10 and male infertility: a meta-analysis.». Journal of assisted reproduction and genetics 30 (9): 1147-56. PMID 23912751. doi:10.1007/s10815-013-0047-5.
Markley HG (October 2012). «CoEnzyme Q10 and riboflavin: the mitochondrial connection». Headache (Review). 52 Suppl 2: 81-7. PMID 23030537. doi:10.1111/j.1526-4610.2012.02233.x.
Yorns WR, Hardison HH (September 2013). «Mitochondrial dysfunction in migraine». Semin Pediatr Neurol 20 (3): 188-93. PMID 24331360. doi:10.1016/j.spen.2013.09.002.
Harper, CR; Jacobson, TA (Sep 2010). «Evidence-based management of statin myopathy.». Current atherosclerosis reports 12 (5): 322-30. PMID 20628837. doi:10.1007/s11883-010-0120-9.
T.L.P. Watts, BDS, MDS, PhD, FDS, Department of Periodontology and Preventive Dentistry, UMDS, Guy's Hospital London (1995). «Coënzyme Q10 and periodontal treatment: is there any beneficial effect?». British Dental Journal 178 (6): 209-213. PMID 7718355. doi:10.1038/sj.bdj.4808715.
Folkers, K; Hanioka, T; Xia, L; McRee Jr, J; Langsjoen, P (1991). «Coenzyme Q₁₀ increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the aids related complex». Biochemical and Biophysical Research Communications 176 (2): 786-91. PMID 1673841. doi:10.1016/S0006-291X(05)80254-2.
Littarru GP, Nakamura R, Ho L, Folkers K, Kuzell WC (October 1971). «Deficiency of Coenzyme Q₁₀ in Gingival Tissue from Patients with Periodontal Disease». Proc. Natl. Acad. Sci. U.S.A. 68 (10): 2332-5. PMC 389415. PMID 5289867. doi:10.1073/pnas.68.10.2332.
Nakamura R, Littarru GP, Folkers K, Wilkinson EG (April 1974). «Study of CoQ₁₀-Enzymes in Gingiva from Patients with Periodontal Disease and Evidence for a Deficiency of Coenzyme Q₁₀». Proc. Natl. Acad. Sci. U.S.A. 71 (4): 1456-60. PMC 388248. PMID 4151519. doi:10.1073/pnas.71.4.1456.
McRee JT, Hanioka T, Shizukuishi S, Folkers K (1993). «Therapy with coenzyme Q₁₀ for patients with periodontal disease». J Dent Health 43 (5): 659-666. doi:10.5834/jdh.43.659.
Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K (1994). «Effect of topical application of coenzyme Q₁₀ on adult periodontitis». Mol. Aspects Med. 15 (Suppl): S241-8. PMID 7752836. doi:10.1016/0098-2997(94)90034-5.
Liu J, Wang LN, Zhan SY, Xia Y (2012). «WITHDRAWN: Coenzyme Q10 for Parkinson's disease». Cochrane Database Syst Rev 5: CD008150. PMID 22592726. doi:10.1002/14651858.CD008150.pub3.
Bentinger, Magnus; Tekle, Michael; Dallner, Gustav (2010-05). «Coenzyme Q – Biosynthesis and functions». Biochemical and Biophysical Research Communications (en inglés) 396 (1): 74-79. doi:10.1016/j.bbrc.2010.02.147. Consultado el 30 de octubre de 2020.
Trevisson, Eva; DiMauro, Salvatore; Navas, Placido; Salviati, Leonardo (2011-10). «Coenzyme Q deficiency in muscle:». Current Opinion in Neurology (en inglés) 24 (5): 449-456. ISSN 1350-7540. doi:10.1097/WCO.0b013e32834ab528. Consultado el 30 de octubre de 2020.
Tan, Jason T.; Barry, Arden R. (1 de junio de 2017). «Coenzyme Q10 supplementation in the management of statin-associated myalgia». American Journal of Health-System Pharmacy (en inglés) 74 (11): 786-793. ISSN 1079-2082. doi:10.2146/ajhp160714. Consultado el 30 de octubre de 2020.

elsevier.com

linkinghub.elsevier.com

Hathcock JN, Shao A (August 2006). «Risk assessment for coenzyme Q₁₀ (Ubiquinone)». Regul. Toxicol. Pharmacol. 45 (3): 282-8. PMID 16814438. doi:10.1016/j.yrtph.2006.05.006.
Montero R, Sánchez-Alcázar JA, Briones P, et al. (June 2008). «Analysis of coenzyme Q₁₀ in muscle and fibroblasts for the diagnosis of CoQ₁₀ deficiency syndromes». Clin. Biochem. 41 (9): 697-700. PMID 18387363. doi:10.1016/j.clinbiochem.2008.03.007.
Bentinger, Magnus; Tekle, Michael; Dallner, Gustav (2010-05). «Coenzyme Q – Biosynthesis and functions». Biochemical and Biophysical Research Communications (en inglés) 396 (1): 74-79. doi:10.1016/j.bbrc.2010.02.147. Consultado el 30 de octubre de 2020.

issn.org

portal.issn.org

Fotino, A Domnica; Thompson-Paul, Angela M; Bazzano, Lydia A (2013-2). «Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis123». The American Journal of Clinical Nutrition 97 (2): 268-275. ISSN 0002-9165. PMC 3742297. PMID 23221577. doi:10.3945/ajcn.112.040741. Consultado el 7 de mayo de 2018.
Lei, Li; Liu, Yan (07 24, 2017). «Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials». BMC cardiovascular disorders 17 (1): 196. ISSN 1471-2261. PMC 5525208. PMID 28738783. doi:10.1186/s12872-017-0628-9. Consultado el 7 de mayo de 2018.
DiNicolantonio, James J; Bhutani, Jaikrit; McCarty, Mark F; O'Keefe, James H (19 de octubre de 2015). «Coenzyme Q10 for the treatment of heart failure: a review of the literature». Open Heart 2 (1). ISSN 2053-3624. PMC 4620231. PMID 26512330. doi:10.1136/openhrt-2015-000326. Consultado el 7 de mayo de 2018.
Armstrong, M. J.; Miyasaki, J. M. (7 de agosto de 2012). «Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology». Neurology (en inglés) 79 (6): 597-603. ISSN 0028-3878. PMC 3413759. PMID 22815556. doi:10.1212/WNL.0b013e318263c443. Consultado el 30 de octubre de 2020.
Trevisson, Eva; DiMauro, Salvatore; Navas, Placido; Salviati, Leonardo (2011-10). «Coenzyme Q deficiency in muscle:». Current Opinion in Neurology (en inglés) 24 (5): 449-456. ISSN 1350-7540. doi:10.1097/WCO.0b013e32834ab528. Consultado el 30 de octubre de 2020.
Tan, Jason T.; Barry, Arden R. (1 de junio de 2017). «Coenzyme Q10 supplementation in the management of statin-associated myalgia». American Journal of Health-System Pharmacy (en inglés) 74 (11): 786-793. ISSN 1079-2082. doi:10.2146/ajhp160714. Consultado el 30 de octubre de 2020.

lww.com

journals.lww.com

Trevisson, Eva; DiMauro, Salvatore; Navas, Placido; Salviati, Leonardo (2011-10). «Coenzyme Q deficiency in muscle:». Current Opinion in Neurology (en inglés) 24 (5): 449-456. ISSN 1350-7540. doi:10.1097/WCO.0b013e32834ab528. Consultado el 30 de octubre de 2020.

neurology.org

Armstrong, M. J.; Miyasaki, J. M. (7 de agosto de 2012). «Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology». Neurology (en inglés) 79 (6): 597-603. ISSN 0028-3878. PMC 3413759. PMID 22815556. doi:10.1212/WNL.0b013e318263c443. Consultado el 30 de octubre de 2020.

nih.gov

ncbi.nlm.nih.gov

Ernster, L; Dallner, G (1995). «Biochemical, physiological and medical aspects of ubiquinone function». Biochimica et Biophysica Acta 1271 (1): 195-204. PMID 7599208. doi:10.1016/0925-4439(95)00028-3.
Okamoto, T; Matsuya, T; Fukunaga, Y; Kishi, T; Yamagami, T (1989). «Human serum ubiquinol-10 levels and relationship to serum lipids». International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition 59 (3): 288-92. PMID 2599795.
Aberg, F; Appelkvist, EL; Dallner, G; Ernster, L (1992). «Distribution and redox state of ubiquinones in rat and human tissues». Archives of biochemistry and biophysics 295 (2): 230-4. PMID 1586151. doi:10.1016/0003-9861(92)90511-T.
Shindo, Y; Witt, E; Han, D; Epstein, W; Packer, L (1994). «Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin». The Journal of investigative dermatology 102 (1): 122-4. PMID 8288904. doi:10.1111/1523-1747.ep12371744.
Trevisson E, Dimauro S, Navas P, Salviati L (October 2011). «Coenzyme Q deficiency in muscle». Curr. Opin. Neurol. 24 (5): 449-56. PMID 21844807. doi:10.1097/WCO.0b013e32834ab528.
Hyson HC, Kieburtz K, Shoulson I, et al. (September 2010). «Safety and tolerability of high-dosage coenzyme Q₁₀ in Huntington's disease and healthy subjects». Mov. Disord. 25 (12): 1924-8. PMID 20669312. doi:10.1002/mds.22408.
Hathcock JN, Shao A (August 2006). «Risk assessment for coenzyme Q₁₀ (Ubiquinone)». Regul. Toxicol. Pharmacol. 45 (3): 282-8. PMID 16814438. doi:10.1016/j.yrtph.2006.05.006.
Montero R, Sánchez-Alcázar JA, Briones P, et al. (June 2008). «Analysis of coenzyme Q₁₀ in muscle and fibroblasts for the diagnosis of CoQ₁₀ deficiency syndromes». Clin. Biochem. 41 (9): 697-700. PMID 18387363. doi:10.1016/j.clinbiochem.2008.03.007.
Kishi, T; Watanabe, T; Folkers, K (1977). «Bioenergetics in clinical medicine XV. Inhibition of coenzyme Q₁₀-enzymes by clinically used adrenergic blockers of beta-receptors». Research communications in chemical pathology and pharmacology 17 (1): 157-64. PMID 17892.
Mortensen, SA; Leth, A; Agner, E; Rohde, M (1997). «Dose-related decrease of serum coenzyme Q₁₀ during treatment with HMG-CoA reductase inhibitors». Molecular aspects of medicine 18 (Suppl): S137-44. PMID 9266515. doi:10.1016/S0098-2997(97)00014-9.
Ghirlanda, G; Oradei, A; Manto, A; Lippa, S; Uccioli, L; Caputo, S; Greco, AV; Littarru, GP (1993). «Evidence of plasma CoQ₁₀-lowering effect by HMG-CoA reductase inhibitors: a double-blind, placebo-controlled study». Journal of Clinical Pharmacology 33 (3): 226-9. PMID 8463436. doi:10.1002/j.1552-4604.1993.tb03948.x.
Sarter, B (2002). «Coenzyme Q₁₀ and cardiovascular disease: a review». Journal of Cardiovascular Nursing 16 (4): 9-20. PMID 12597259. doi:10.1097/00005082-200207000-00003.
Thibault, A; Samid, D; Tompkins, AC; Figg, WD; Cooper, MR; Hohl, RJ; Trepel, J; Liang, B; Patronas, N; Venzon, DJ; Reed, E; Myers, CE (1996). «Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer». Clinical Cancer Research 2 (3): 483-91. PMID 9816194.
Wyman M, Leonard M, Morledge T (July 2010). «Coenzyme Q10: a therapy for hypertension and statin-induced myalgia?». Cleve Clin J Med 77 (7): 435-42. PMID 20601617. doi:10.3949/ccjm.77a.09078.
Flowers, N; Hartley, L; Todkill, D; Stranges, S; Rees, K (4 de diciembre de 2014). «Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.». The Cochrane database of systematic reviews 12: CD010405. PMID 25474484.
Ho, MJ; Bellusci, A; Wright, JM (7 de octubre de 2009). «Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.». The Cochrane database of systematic reviews (4): CD007435. PMID 19821418. doi:10.1002/14651858.CD007435.pub2.
Fotino, A Domnica; Thompson-Paul, Angela M; Bazzano, Lydia A (2013-2). «Effect of coenzyme Q10 supplementation on heart failure: a meta-analysis123». The American Journal of Clinical Nutrition 97 (2): 268-275. ISSN 0002-9165. PMC 3742297. PMID 23221577. doi:10.3945/ajcn.112.040741. Consultado el 7 de mayo de 2018.
Lei, Li; Liu, Yan (07 24, 2017). «Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials». BMC cardiovascular disorders 17 (1): 196. ISSN 1471-2261. PMC 5525208. PMID 28738783. doi:10.1186/s12872-017-0628-9. Consultado el 7 de mayo de 2018.
DiNicolantonio, James J; Bhutani, Jaikrit; McCarty, Mark F; O'Keefe, James H (19 de octubre de 2015). «Coenzyme Q10 for the treatment of heart failure: a review of the literature». Open Heart 2 (1). ISSN 2053-3624. PMC 4620231. PMID 26512330. doi:10.1136/openhrt-2015-000326. Consultado el 7 de mayo de 2018.
Armstrong, M. J.; Miyasaki, J. M. (7 de agosto de 2012). «Evidence-based guideline: Pharmacologic treatment of chorea in Huntington disease: Report of the Guideline Development Subcommittee of the American Academy of Neurology». Neurology (en inglés) 79 (6): 597-603. ISSN 0028-3878. PMC 3413759. PMID 22815556. doi:10.1212/WNL.0b013e318263c443. Consultado el 30 de octubre de 2020.
Lafuente, R; González-Comadrán, M; Solà, I; López, G; Brassesco, M; Carreras, R; Checa, MA (Sep 2013). «Coenzyme Q10 and male infertility: a meta-analysis.». Journal of assisted reproduction and genetics 30 (9): 1147-56. PMID 23912751. doi:10.1007/s10815-013-0047-5.
Markley HG (October 2012). «CoEnzyme Q10 and riboflavin: the mitochondrial connection». Headache (Review). 52 Suppl 2: 81-7. PMID 23030537. doi:10.1111/j.1526-4610.2012.02233.x.
Yorns WR, Hardison HH (September 2013). «Mitochondrial dysfunction in migraine». Semin Pediatr Neurol 20 (3): 188-93. PMID 24331360. doi:10.1016/j.spen.2013.09.002.
Pringsheim T, Davenport W, Mackie G, et al. (March 2012). «Canadian Headache Society guideline for migraine prophylaxis». Can J Neurol Sci 39 (2 Suppl 2): S1-59. PMID 22683887.
Harper, CR; Jacobson, TA (Sep 2010). «Evidence-based management of statin myopathy.». Current atherosclerosis reports 12 (5): 322-30. PMID 20628837. doi:10.1007/s11883-010-0120-9.
T.L.P. Watts, BDS, MDS, PhD, FDS, Department of Periodontology and Preventive Dentistry, UMDS, Guy's Hospital London (1995). «Coënzyme Q10 and periodontal treatment: is there any beneficial effect?». British Dental Journal 178 (6): 209-213. PMID 7718355. doi:10.1038/sj.bdj.4808715.
Folkers, K; Hanioka, T; Xia, L; McRee Jr, J; Langsjoen, P (1991). «Coenzyme Q₁₀ increases T4/T8 ratios of lymphocytes in ordinary subjects and relevance to patients having the aids related complex». Biochemical and Biophysical Research Communications 176 (2): 786-91. PMID 1673841. doi:10.1016/S0006-291X(05)80254-2.
Littarru GP, Nakamura R, Ho L, Folkers K, Kuzell WC (October 1971). «Deficiency of Coenzyme Q₁₀ in Gingival Tissue from Patients with Periodontal Disease». Proc. Natl. Acad. Sci. U.S.A. 68 (10): 2332-5. PMC 389415. PMID 5289867. doi:10.1073/pnas.68.10.2332.
Nakamura R, Littarru GP, Folkers K, Wilkinson EG (April 1974). «Study of CoQ₁₀-Enzymes in Gingiva from Patients with Periodontal Disease and Evidence for a Deficiency of Coenzyme Q₁₀». Proc. Natl. Acad. Sci. U.S.A. 71 (4): 1456-60. PMC 388248. PMID 4151519. doi:10.1073/pnas.71.4.1456.
Hanioka T, Tanaka M, Ojima M, Shizukuishi S, Folkers K (1994). «Effect of topical application of coenzyme Q₁₀ on adult periodontitis». Mol. Aspects Med. 15 (Suppl): S241-8. PMID 7752836. doi:10.1016/0098-2997(94)90034-5.
Wilkinson, EG; Arnold, RM; Folkers, K (1976). «Bioenergetics in clinical medicine. VI. adjunctive treatment of periodontal disease with coenzyme Q₁₀». Research communications in chemical pathology and pharmacology 14 (4): 715-9. PMID 785563.
Liu J, Wang LN, Zhan SY, Xia Y (2012). «WITHDRAWN: Coenzyme Q10 for Parkinson's disease». Cochrane Database Syst Rev 5: CD008150. PMID 22592726. doi:10.1002/14651858.CD008150.pub3.

nist.gov

webbook.nist.gov

Número CAS

oup.com

academic.oup.com

Tan, Jason T.; Barry, Arden R. (1 de junio de 2017). «Coenzyme Q10 supplementation in the management of statin-associated myalgia». American Journal of Health-System Pharmacy (en inglés) 74 (11): 786-793. ISSN 1079-2082. doi:10.2146/ajhp160714. Consultado el 30 de octubre de 2020.

web.archive.org

«Coenzyme Q10». American Cancer Society. Archivado desde el original el 24 de febrero de 2014. Consultado el 20 de febrero de 2014.

wiley.com

onlinelibrary.wiley.com

Madmani, M.E.; Yusuf Solaiman, A.; Tamr Agha, K.; Madmani, Y. et al. (2 de junio de 2014). «Coenzyme Q10 for heart failure». Heart Group. Cochrane Database of Systematic Reviews (John Wiley & Sons) (6): Art. no. CD008684. doi:10.1002/14651858.CD008684.pub2 – via The Cochrane Library. (requiere suscripción).

wkhealth.com

meta.wkhealth.com

Trevisson E, Dimauro S, Navas P, Salviati L (October 2011). «Coenzyme Q deficiency in muscle». Curr. Opin. Neurol. 24 (5): 449-56. PMID 21844807. doi:10.1097/WCO.0b013e32834ab528.

worldcat.org

Espinós, Carmen.; Felipo, Vicente.; Palau, Francesc. (2009). Inherited neuromuscular diseases : translation from pathomechanisms to therapies. Springer. p. 122ff. ISBN 978-90-481-2813-6. OCLC 656365967. Consultado el 30 de octubre de 2020.